Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: GlobeNewswire
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) or certain of its executive officers violated federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws. What if I purchased Amphastar securities?If you purchased Amphastar securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation. Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471. There is no cost or obligation to you. Background of the InvestigationOn May 7, 2026, Amphastar reported its financial results for the first quarter of 2026. The Company disclosed that BAQSIMI revenues decreased 15% year-over-year to $32.4 million, compared to $38.4 million in the prior-year period, despite an 8% increase in units sold. Amphastar attributed the BAQSIMI revenue decline to lower a
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar unit gets FDA warning letter over manufacturing violations [Seeking Alpha]Seeking Alpha
- Amphastar Pharmaceuticals (AMPH) had its "underperform" rating reaffirmed by Bank of America Corporation. They now have a $20.00 price target on the stock, down from $25.00.MarketBeat
- Amphastar Pharmaceuticals (AMPH) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- How The Investment Story For Amphastar Pharmaceuticals (AMPH) Is Evolving Without New Valuation Shifts [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 5/7/26 - Miss
AMPH
Sec Filings
- 7/8/26 - Form 8-K
- 6/3/26 - Form 4
- 6/3/26 - Form 4
- AMPH's page on the SEC website